Stephen L. Huhn - CMO & Sr VP, Clinical Dev. at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CMO & Sr VP, Clinical Dev.
Stock Symbol
CTNM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen L. Huhn since 12/22/2023

Holdings reported by Stephen L. Huhn for Contineum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 12.8K $218K $17.05 Aug 13, 2024 Direct
Stock Option (right to buy) 161K Aug 13, 2024 Direct Class A Common Stock

Transactions reported by Stephen L. Huhn for Contineum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.